Viral polymerase and modulation thereof
AssigneeMelbourne Health
InventorsAngeline Bartholomeusz, David Chalmers, Mike Kuiper, Ben Tehan
Life of this patent
Estimating the term…
Loading patent…
AssigneeMelbourne Health
InventorsAngeline Bartholomeusz, David Chalmers, Mike Kuiper, Ben Tehan
Estimating the term…
The present invention provides the tertiary structure of a Hepatitis B Virus (HBV) polymerase reverse transcriptase (rt) domain from which a variant HBV polymerase mutations associated with resistance to or having reduced sensitivity to an anti-viral drug have been mapped. The present invention further provides methods of identifying, designing and/or modifying agents capable of modulating the functional activity of the HBV polymerase based on the atomic co-ordinates provided by the tertiary structure. The present invention still further provides a method of modulating HBV polymerase functional activity and agents useful for same. The agents identified in accordance with the method of the present invention are particularly useful inter alia in the treatment and/or prophylaxis of infection by an HBV resistant to or exhibiting reduced sensitivity to an anti-viral drug. The agents may also have utility as diagnostic agents such as to distinguish between resistance mutations. Furthermore, the present invention enables responses of particular potential anti-viral drugs to be predicted. In addition, new targets within the polymerase have been identified.
A method for identifying the spatial position of an amino acid adjacent to an amino acid mutation conferring resistance to a DNA polymerase antagonist within a reverse transcriptase domain of a DNA polymerase from a Hepatitis B virus (HBV), said method comprising:
A computer-assisted method to identify a potential HBV DNA polymerase antagonist comprising the steps of:
A computer or a software component thereof that produces a three-dimensional representation of a molecule or molecular complex, which comprises a three-dimensional representation of a homolog of the molecule or molecular complex, which comprises a three-dimensional representation of a homolog of the molecule or molecular complex, in which the homolog comprises a domain that has a root mean square deviation from the backbone atoms of the amino acids of not more than 1.5 Å, in which the computer comprises:
A computer or a software component thereof that determines the structure co-ordinates corresponding to a three-dimensional structure of a molecule or molecular complex comprising an HBV polymerase, said computer comprises:
A computer-assisted method to identify or design HBV DNA polymerase antagonists that bind to a domain of HBV polymerase comprising the steps of:
A method of identifying an agent capable of interacting with a variant DNA polymerase or from an HBV resistant to a DNA polymerase antagonist, the variant comprising a mutation selected from the group consisting of:
Use of an HBV DNA polymerase comprising amino acid residues selected from the group consisting of:
A method for screening for an agent capable of binding to and/or inhibiting an BHV polymerase, the method comprising:
A diagnostic agent comprising a molecule capable of binding, associating with or interacting with a region of an HBV DNA polymerase defined at or near amino acid residues selected from the group consisting of:
Dependencies are inferred from the claim text.